Journal of Capital Medical University ›› 2018, Vol. 39 ›› Issue (6): 877-882.doi: 10.3969/j.issn.1006-7795.2018.06.015

Previous Articles     Next Articles

Divergent distribution of dopamine receptors in tumor β-cell lines and in situ

Li Ji, Li Guangwen, Zhang Yue, Zhu Jinxia   

  1. Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China
  • Received:2018-07-03 Online:2018-11-21 Published:2018-12-19
  • Supported by:
    This study was supported by National Natural Science Foundation of China (91739120).

Abstract: Objective To investigate distribution of dopamine (DA) receptors in rat pancreatic tissue and β-cells lines (INS-1 and HIT-T15 cells) and further the endocrine function of INS-1 cell. Methods Double-labeled immunofluorescence staining was used to observe the differential distribution of dopamine receptors and immunofluorescence of insulin and glucagon between in rat pancreatic tissue and tumor β-cell lines. The insulin and glucagon content in the supernatant of INS-1 cell line was detected by radioimmunoassay to observe the changes of endocrine function. Results In rat pancreatic tissue, DA receptors D1, D2, and D5 were distributed in the β-cells, δ-cells, and α-cells, PP-cells, respectively, that is, β-cells expressed only D1 receptors. However, not only D1, but also D2 and D5 were distributed in the INS-1 and HIT-T15 β-cell lines. Insulin and glucagon immunoreactivities were simultaneously expressed in the β-cell lines. Furthermore, both the insulin and glucagon were detected in the supernatant of INS-1 β-cell line. Conclusion The present study for the first time demonstrated that the distribution of DA receptors and endocrine function in β-cell lines are different from that in situ.

Key words: dopamine receptors, β cells, INS-1 cells, HIT-T15 cells

CLC Number: